-
TIME
Sunday, January 11, 2026
-
08:00 – 09:00
Registration
-
09:00 – 09:15
Opening Remark – Global Healthcare Capital & BD Outlook
Speaker:
David Chen, Founder & Managing Director, BFC Group
-
09:15 – 10:15
Capital Shifts – The Evolving Global Biotech Investment Landscape
Moderator:
Patrick Loofbourrow, Partner, Cooley
Distinguished Speakers:
David Wang, Partner and Senior Managing Director, OrbiMed
Brian Chow, Managing Director, Deerfield Management
Kevin Chen, Founding Partner & CEO, BioTrack Capital
Ricky Sun, Partner, Bain Capital
Amit Kakar, Managing Partner, Novo Holdings
-
10:15 – 11:15
From Asia to the World – Redefining Global Pharma Collaboration
Moderator:
Thijs Spoor, CEO, Perspective Therapeutics
Distinguished Speakers:
Julie Rozenblyum, Senior Vice President, Business Development, Bristol Myers Squibb
Markus Werner, Head Search & Evaluation Oncology, Novartis
Johan Verbeeck, Vice President Business Development, Oncology, Johnson & Johnson Innovative Medicine
Michelle Li, Senior Vice President, Head of Business Development and Alliance Management, Alnylam Pharmaceuticals
Wendy Liu, Vice President, Worldwide Business Development, Pfizer
-
11:15 – 11:45
Coffee Break
-
11:45 – 12:45
The Rise of Therapeutic Convergence – Addressing Unmet Needs with New Frontiers
Moderator:
Lila Hope, Partner, Cooley
Distinguished Speakers:
Matthieu Merlin, Head of Business Development General Medicines GBU, Sanofi
Tomohiro Yamauchi, Head of Scouting & Transaction Oncology, Business Development, Astellas Pharma
Remko Bakker, Global Head of Eye Health and Research Beyond Borders, Boehringer Ingelheim
Enza Di Modugno, VP Roche Pharma Partnering, Global Head CVM, Immunology, Infectious Diseases, Roche
Albert Ren, Vice President, Strategy & Business Development, Pfizer China
-
13:45 – 17:00
Company Roadshow
-
17:00 – 18:00
Accessing Early Innovation – Shaping the Next Wave of Biotech
Moderator:
Roel van den Akker, Partner, Pharmaceutical & Life Science Deals Leader, PwC US
Distinguished Speakers:
Neville Mehenti, Executive Director, Head of Oncology Corporate Development, Gilead Science
Eric Yeung, Vice President, Head of Oncology and Rare Diseases Global Business Development, Takeda
Regina Salvat, Principal, Forbion
Ryan Wang, Vice President, Head of Lilly China Innovation and Partnerships, Eli Lilly
Mads Frederik Rasmussen, SVP, R&D External Innovation, Novo Nordisk
